Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SRRA

Sierra Oncology (SRRA) Stock Price, News & Analysis

Sierra Oncology logo

About Sierra Oncology Stock (NASDAQ:SRRA)

Advanced Chart

Key Stats

Today's Range
$54.99
$54.99
50-Day Range
$54.73
$54.99
52-Week Range
$14.91
$55.19
Volume
N/A
Average Volume
931,731 shs
Market Capitalization
$1.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SRRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sierra Oncology and its competitors with MarketBeat's FREE daily newsletter.

SRRA Stock News Headlines

Sierra Oncology Inc.
Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rally right now. Over the past few weeks alone, the yellow metal surged as high as $3,500 — the highest level on record. So far this bull run playing out exactly as me and my analysts have predicted.
Sierra Coupon for October
See More Headlines

SRRA Stock Analysis - Frequently Asked Questions

Sierra Oncology, Inc. (NASDAQ:SRRA) posted its earnings results on Friday, November, 5th. The biotechnology company reported ($2.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.78) by $0.32.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sierra Oncology investors own include Onconova Therapeutics (ONTX), VBI Vaccines (VBIV), T2 Biosystems (TTOO), OPKO Health (OPK), Tonix Pharmaceuticals (TNXP), Trevena (TRVN) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
11/05/2021
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SRRA
Previous Symbol
NASDAQ:DNAI
CIK
1290149
Fax
N/A
Employees
109
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$94.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-111.88%
Return on Assets
-100.01%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
21.27
Quick Ratio
21.27

Sales & Book Value

Annual Sales
$300 thousand
Price / Sales
4,476.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.16 per share
Price / Book
8.93

Miscellaneous

Outstanding Shares
24,419,000
Free Float
13,650,000
Market Cap
$1.34 billion
Optionable
Optionable
Beta
0.03

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:SRRA) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners